Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEC11B is a putative catalytic subunit of the signal peptidase complex, an essential multi-protein assembly in eukaryotes that removes signal peptides from nascent secretory and membrane proteins as they enter the lumen of the endoplasmic reticulum[3][5][6][9]. The complex is crucial for the maturation and proper functioning of many proteins. SEC11B, as a member of the serine protease family, is predicted to harbor catalytic activity, although its functional characterization in humans is limited and it remains less well-studied compared to the main SEC11A subunit. There are no established disease associations, drug interactions, or therapeutic implications registered for SEC11B at present[3][5][9]. Its essential function in archaea and possible redundancy in higher eukaryotes suggest a conserved biological role in protein maturation[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal peptidase complex catalytic subunit SEC11B (SEC11B).